By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


ImmunoCellular Therapeutics, Ltd 

23622 Calabasas Road
Suite 300
Calabasas  California  91302  U.S.A.
Phone: 818-264-2300 Fax: 818-224-5287



Company News
ImmunoCellular Therapeutics (IMUC) Announces First Quarter 2017 Financial Results 5/16/2017 10:56:28 AM
ImmunoCellular Therapeutics (IMUC) And Memgen Announce Letter Of Intent For Potential Joint Immuno-Oncology Collaboration 3/23/2017 8:28:32 AM
ImmunoCellular Therapeutics (IMUC) Receives Audit Opinion With Going Concern Explanation 3/15/2017 9:54:39 AM
ImmunoCellular Therapeutics (IMUC) Announces Fourth Quarter And Full Year 2016 Financial Results And Provides Corporate Update 3/10/2017 7:34:17 AM
ImmunoCellular Therapeutics (IMUC) To Report Fourth Quarter And Full Year 2016 Financial Results On March 9, 2017 3/7/2017 9:35:28 AM
ImmunoCellular Therapeutics (IMUC) Provides Update On ICT-107 Phase III Glioblastoma Trial And Announces Advances In Stem-To-T-Cell Research Program 3/6/2017 6:23:52 AM
SAVSU Provides Performance Update On Evo Cold Chain 2.0 System In ImmunoCellular Therapeutics (IMUC) Phase lll Glioblastoma Cell Therapy Clinical Trial 2/14/2017 6:43:26 AM
SoCal's ImmunoCellular Therapeutics (IMUC) Names a New CEO, Effectively Immediately 12/15/2016 6:43:03 AM
ImmunoCellular Therapeutics, Ltd (IMUC) Reports Updated Immune Monitoring Data From ICT-107 Phase 2 Trial In Newly Diagnosed Glioblastoma At The Society For Neuro-Oncology Annual Meeting 2016 11/21/2016 6:53:06 AM
ImmunoCellular Therapeutics, Ltd (IMUC) Announces One-for-Forty Reverse Stock Split 11/16/2016 8:29:05 AM